This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SUMMARY
- The company cannot recommend any practices, procedures, or storage conditions that deviate from product labeling and are not approved by the regulatory agencies.
- RYBREVANT FASPRO does not contain an antimicrobial preservative. Administer RYBREVANT FASPRO dose in prepared syringes immediately.1
- If immediate administration is not possible, store the prepared syringes of RYBREVANT FASPRO refrigerated at 2°C to 8°C (36°F to 46°F) for up to 24 hours, followed by at room temperature of 15°C to 30°C (59°F to 86°F) for up to 24 hours.1
- Discard the prepared syringe(s) if stored for more than 24 hours refrigerated or more than 24 hours at room temperature. If stored in the refrigerator, allow the solution to come to room temperature before administration.1
- Please refer to the DOSAGE AND ADMINISTRATION section of the full Prescribing Information for RYBREVANT FASPRO for complete information.1
Literature Search
A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) was conducted on 09 December 2025.